Amitava Mitra - Concepedia

Author

Amitava Mitra

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A. Mitra, Amitava Mitra, Pau Montesinos

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Novartis (United States)Janssen (Belgium)Simulations Plus (United States)United States Military Academy

About

Amitava Mitra is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	33	1.6K
2	Engineering	7	7	368
3	Natural Sciences	3	3	134
4	Humanities	1	1	13
5	Law	1	1	13

Amitava Mitra

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Targeting tumor angiogenic vasculature using polymer–RGD conjugates Amitava Mitra, Justin Mulholland, Anjan Nan, Journal of Controlled Release AngiogenesisPolymer-drug ConjugatePolymer–rgd ConjugatesVascular BiologyBiomedical Engineering	2004	148
Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates. Bruce R. Line, Amitava Mitra, Anjan Nan, PubMed	2005	108
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link—a Workshop Summary Report Tycho Heimbach, Sandra Suarez‐Sharp, Maziar Kakhi, The AAPS Journal Tissue EngineeringRegenerative MedicineEngineeringPharmacokinetic ModelingIn Vivo System	2019	102
Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting Amitava Mitra, Tomika Coleman, Mark P. Borgman, Journal of Controlled Release Bi-cyclic αVβ3Peptide EngineeringPolymeric ConjugatesPeptide LibraryMolecular Biology	2006	85
<i>In Silico</i> Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole Bart Hens, Shriram M. Pathak, Amitava Mitra, Molecular Pharmaceutics Gastric DissolutionPharmacokinetic ModelingMedicineIdentical CsrPhysiology	2017	72
Application of Absorption Modeling to Predict Bioequivalence Outcome of Two Batches of Etoricoxib Tablets Amitava Mitra, Filippos Kesisoglou, Peter Dogterom AAPS PharmSciTech Etoricoxib TabletsBioequivalenceMedicinePhysiologyPharmacology	2014	69
Polymer-peptide conjugates for angiogenesis targeted tumor radiotherapy Amitava Mitra, Anjan Nan, John C. Papadimitriou, Nuclear Medicine and Biology Polymer-drug ConjugatePolymer-peptide ConjugatesPeptide TherapeuticsTumor TargetingBiomedical Engineering	2006	67
Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems Amitava Mitra, Senshang Lin Journal of Pharmacy and Pharmacology NanomedicineEngineeringPolymer-drug ConjugateMedicinePolymer Science	2003	67
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results Alison Margolskee, Adam S. Darwich, Xavier Pépin, European Journal of Pharmaceutical Sciences Pharmacokinetic ModelingMedicineProcess Analytical TechnologyBiostatisticsSimulation Exercise	2016	66
An In-Depth View into Human Intestinal Fluid Colloids: Intersubject Variability in Relation to Composition Danny Riethorst, Peter Baatsen, Caroline Remijn, Molecular Pharmaceutics Food ColloidState HifGastroenterologyPathologyIntersubject Variability	2016	61

Page 1